Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.
  • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 44.3% to $4.7893 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target.
  • IMARA Inc. (NASDAQ:IMRA) rose 37% to $1.57 after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront.
  • Sidus Space, Inc. (NASDAQ:SIDU) gained 26.7% to $3.3701 after the company announced that it has signed a launch agreement with SpaceX for five launches, beginning in early 2023.
  • Cryo-Cell International, Inc. (NYSE:CCEL) jumped 17.7% to $7.86.
  • bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 19.7% to $6.45 after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
  • Azure Power Global Limited (NYSE:AZRE) shares gained 17.3% to $4.21. Azure Power Global recently announced the resignation of Harsh Shah as CEO.
  • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) jumped 17.3% to $0.8565.
  • Glaukos Corporation (NYSE:GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary efficacy endpoints through 3 months in both Phase 3 trials and demonstrated excellent tolerability and a favorable safety profile through 12 months.
  • Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 16.8% to $1.4599. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
  • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares rose 16.4% to $1.3150. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
  • Biophytis S.A. (NASDAQ:BPTS) shares gained 16% to $1.0899 after the company released topline results from its phase 2-3 COVA study evaluating Sarconeos (BIO101) in treating COVID-19-related respiratory failure.
  • SelectQuote, Inc. (NYSE:SLQT) rose 15.4% to $1.2808.
  • Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 14.2% to $6.16. Seres Therapeutics announced completion of rolling BLA submission to the FDA for investigational microbiome therapeutic SER-109 for recurrent C. Difficile infection.
  • Academy Sports and Outdoors, Inc. (NASDAQ:ASO) jumped 12% to $46.98. Academy Sports And Outdoors reported a second-quarter FY22 sales decline of 5.8% year-on-year to $1.69 billion.
  • Nutex Health, Inc. (NASDAQ:NUTX) jumped 11.5% to $2.90.
  • Unico American Corporation (NASDAQ:UNAM) gained 10.6% to $1.8580.
  • Coupa Software Incorporated (NASDAQ:COUP) rose 10.5% to $61.65 as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
  • Tempur Sealy International, Inc. (NYSE:TPX) jumped 8.2% to $26.39.
  • InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 7.6% to $9.47.
  • Baudax Bio, Inc. (NASDAQ:BXRX) rose 7.6% to $0.3243 after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.


Losers

  • Great Panther Mining Limited (NYSE:GPL) dropped 65% to $0.2801. Great Panther recently announced it will file a notice of intention to make a proposal under the Bankruptcy and Insolvency Act (Canada).
  • CleanTech Acquisition Corp. (NASDAQ:CLAQ) shares fell 36.4% to $6.03 after the company reported shareholder voting results in 8K filing.
  • NewAge, Inc. (NASDAQ:NBEV) shares dipped 25% to $0.0937 after dipping over 15% on Tuesday. The company recently announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
  • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 22.8% to $1.96.
  • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares dipped 20.6% to $3.35 after jumping around 33% on Tuesday. First Wave BioPharma recently announced a 1:30 reverse stock split.
  • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 18.3% to $1.7001. Presidio Property Trust recently declared Q3 dividend and adopted variable dividend policy.
  • Golden Path Acquisition Corporation (NASDAQ:GPCO) dropped 17.5% to $8.46.
  • AMTD Digital Inc. (NYSE:HKD) dropped 16.4% to $57.63.
  • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) declined 16.3% to $0.1842. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
  • UiPath Inc. (NYSE:PATH) fell 13.9% to $13.43 after the company issued Q3 and FY23 sales guidance below analyst estimates.
  • John Wiley & Sons, Inc. (NYSE:WLY) dropped 13.6% to $39.81 after the company reported worse-than-expected Q1 EPS and sales results.
  • Veru Inc. (NASDAQ:VERU) declined 13.5% to $12.62. Traders circulate word FDA decision on the company’s COVID treatment coming on Oct. 6.
  • FaZe Holdings Inc. (NASDAQ:FAZE) dipped 12.1% to $12.06.
  • Mobile Global Esports Inc. (NASDAQ:MGAM) dropped 11% to $2.4289.
  • Vacasa, Inc. (NASDAQ:VCSA) fell 9.5% to $3.6450.
  • DBV Technologies S.A. (NASDAQ:DBVT) fell 8.5% to $2.15 after gaining around 8% on Tuesday. DBV Technologies, last month, posted a Q2 loss of $0.35 per share.
  • Korn Ferry (NYSE:KFY) fell 8.2% to $55.26 following downbeat quarterly earnings.
  • G-III Apparel Group, Ltd. (NASDAQ:GIII) dropped 5.6% to $18.73 after the company posted downbeat quarterly earnings and lowered FY23 forecast.
  • GameStop Corp. (NYSE:GME) fell 4.5% to $24.00 ahead of quarterly earnings.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.